Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy
      Description

      The purpose of this study is to determine whether AFQ056 as an add on therapy to SSRIs can have beneficial effects by reducing the total score of Y-BOCS (Yale and Brown Obsessive Compulsive Scale) in OCD patients resistant to SSRI treatment (failed SSRI over 12 weeks at appropriate doses).

      Conditions
      Patient Diagnosed With OCD and Resistant to SSRI TreatmentFailed SSRI Over 12 Weeks at Appropriate Doses
      Talk to us